EU Council Agrees Compromise Position On Joint Clinical Assessments
Industry Split On Whether It’s Progress Or A Letdown
The Alliance For Regenerative Medicines is calling for advanced therapies to be given greater priority where joint clinical assessments are concerned.
You may also be interested in...
The European Parliament and EU Council have reached an agreement on taking forward proposals for greater cooperation on health technology assessments.
Transparency on pricing and cost calculations could improve and inform public policy on medicines access, say EU health ministers.
The umbrella organization for public insurers is also expected to publish its own suggestions on how to cut spending on pharmaceuticals, including interim prices for conditionally approved drugs.